Mutares Aktie 43469302 / DE000A2NB650
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
28.10.2025 08:00:13
|
EQS-News: Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China
|
EQS-News: Mutares SE & Co. KGaA
/ Key word(s): Investment/Takeover
Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China
Munich, October 28, 2025 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has entered into final negotiations with Korean listed Hwaseung Corporation to acquire 67% of the shares in Hwaseung Special Rubber (Taicang) Co., Ltd. (“HSR”) and Hwaseung Auto Parts (Taicang) Co., Ltd. (“HST”). This potential acquisition of a majority stake in a leading automotive supplier in China marks a significant milestone in Mutares’ global expansion and targeted growth strategy in Asia. Hwaseung Corporation today disclosed the potential takeover on the Korean stock exchange. Signing of the transaction is envisaged for the fourth quarter of 2025. The targeted companies are renowned for their indispensable rubber sealing and hose products, serving blue-chip automotive OEMs such as GM, VW, Hyundai, Kia, and Xiaomi. With two state-of-the-art manufacturing sites and a workforce of approximately 600 employees, the companies generated revenues of over EUR 100 million in 2024. HSR and HST make a perfect fit for Amaneos China, unlocking significant value-chain synergies, particularly through the integration with SMA China and SFC China, enabling cost optimization, operational improvements, and a strengthened competitive position in the world’s most dynamic automotive market. Mutares’ entry into China’s automotive sector reinforces its position as an operational frontrunner in the Automotive & Mobility segment, extending the Group’s track record and opening new opportunities for collaboration with leading Asian and international OEMs. The decision by a prominent Korean stock exchange listed seller to transact with Mutares reflects the Group’s global standing as reliable and value-creating owner with a proven track record in operational excellence, transformation, and sustainable growth. Johannes Laumann, CIO of Mutares, comments: “Our expansion into Asia marks a major milestone for Mutares in the Automotive & Mobility segment. We are honored by the trust of our Korean partners and excited to bring our operational expertise to the Chinese market. This acquisition is a testament to our commitment to international growth and diversification, and it will generate value for all stakeholders.”
Company profile of Mutares SE & Co. KGaA Mutares SE & Co. KGaA, Munich (http://www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process. For more information, please contact: Mutares SE & Co. KGaA Press Contact in Germany Press Contact in France Press Contact in UK
28.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Mutares SE & Co. KGaA |
| Arnulfstr.19 | |
| 80335 Munich | |
| Germany | |
| Phone: | +49 (0)89-9292 776-0 |
| Fax: | +49 (0)89-9292 776-22 |
| E-mail: | ir@mutares.de |
| Internet: | www.mutares.de |
| ISIN: | DE000A2NB650 |
| WKN: | A2NB65 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2218488 |
| End of News | EQS News Service |
|
|
2218488 28.10.2025 CET/CEST
Nachrichten zu Mutares
|
12:26 |
Minuszeichen in Frankfurt: SDAX mit Abgaben (finanzen.ch) | |
|
09:28 |
Freundlicher Handel in Frankfurt: SDAX liegt zum Start im Plus (finanzen.ch) | |
|
28.10.25 |
Börse Frankfurt: SDAX zeigt sich letztendlich leichter (finanzen.ch) | |
|
28.10.25 |
Schwacher Handel: SDAX am Nachmittag in der Verlustzone (finanzen.ch) | |
|
28.10.25 |
Schwacher Handel in Frankfurt: So entwickelt sich der SDAX mittags (finanzen.ch) | |
|
28.10.25 |
Schwacher Wochentag in Frankfurt: SDAX liegt zum Handelsstart im Minus (finanzen.ch) | |
|
28.10.25 |
EQS-News: Mutares plant Ausbau der Präsenz in Asien mit strategischer Add-on-Akquisition von HSR und HST von Hwaseung Corporation für Amaneos China (EQS Group) | |
|
28.10.25 |
EQS-News: Mutares plans to expand its presence in Asia with strategic add-on acquisition of HSR and HST from Hwaseung Corporation for Amaneos China (EQS Group) |
Analysen zu Mutares
| 12.08.25 | Mutares Buy | Jefferies & Company Inc. | |
| 17.06.25 | Mutares Buy | Warburg Research | |
| 30.04.25 | Mutares Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 08.11.24 | Mutares Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 17.10.24 | Mutares Buy | Hauck Aufhäuser Lampe Privatbank AG |
Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall
Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.
Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.
🎯 Themen im Interview mit Etienne Jornod (OM Pharma)
– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Vor US-Zinsentscheid: SMI schwächer -- DAX sinkt -- Wall Street startet fester -- Asiens Börsen letztlich im Plus - Nikkei mit AllzeithochDer heimische Aktienmarkt macht zur Wochenmitte leichte Velruste. Der deutsche Aktienmarkt tendiert am Mittwoch leicht abäwrts. An der Wall Street setzt sich die jüngste Rekordjagd fort. Die wichtigsten Aktienmärkte in Fernost verbuchten teilweise große Gewinne.


